Results 171 to 180 of about 13,775 (209)
Some of the next articles are maybe not open access.
Buccal versus Intravaginal Administration of Misoprostol for Labor Induction
Journal of Wasit for Science and Medicine, 2022Objective: The purpose of this study is to compare the efficacy of misoprostol that is administrated in the buccal pouch with the intravaginal route. Study design: Ninety eight pregnant women with a singleton live gestation. Bishop score of < 5, gestational ages of > 37 wks were randomized receives misoprostol that would be placed either in
Sajda A. Rubaee, Ghufran Jaffer
openaire +1 more source
Buccal versus intravaginal misoprostol administration for cervical ripening
American Journal of Obstetrics and Gynecology, 2002The purpose of this study was to compare the efficacy of misoprostol that is administered in the buccal pouch with the intravaginal route of administration.One hundred fifty-seven pregnant women with a singleton live gestation, Bishop score of
S J, Carlan +2 more
openaire +2 more sources
Induction of labor with intravaginal administration of misoprostol
International Journal of Gynecology & Obstetrics, 1998AbstractObjective: The purpose of this study was to evaluate the efficacy and safety of intravaginal misoprostol for labor induction. Methods: 110 singleton term pregnancies with or without rupture of membranes were enrolled. Fractionated doses of misoprostol were applied (50–100 μg), every 6 h until a maximum of three doses or beginning of labor ...
R, Rodrigues +5 more
openaire +2 more sources
Plasma Progesterone Concentrations After Administration via Intravaginal Rings
Acta Obstetricia et Gynecologica Scandinavica, 1979Intravaginal rings (IVRs) fabricated from polysiloxane (silastic 382) and containing 708+ or -4.7 mg of progesterone (P) in the polysiloxane core of the ring were tested for efficacy of natural P administration through this route. 8 women volunteered.
T, Bäckström +2 more
openaire +2 more sources
Midtrimester pregnancy termination by intravaginal administration of prostaglandin E2
Contraception, 1982The intravaginal administration of prostaglandin E2 (PGE2) in repeated doses of 20 mg was evaluated for efficacy and safety in 400 midtrimester pregnancy terminations. Patients were assigned to three treatment groups. Group A (232 patients) received PGE2 alone, Group B (106 patients) had prior intracervical laminaria insertion, Group C (62 patients ...
E J, Surrago, J, Robins
openaire +2 more sources
Serum steroid levels during 12-week intravaginal dehydroepiandrosterone administration
Menopause, 2009Because a previous 1-week study has shown no or minimal changes in the serum levels of dehydroepiandrosterone (DHEA) and its metabolites after up to daily 1.8% (23.4 mg) intravaginal DHEA, the objective of the present study was to investigate the serum steroid levels during a 12-week daily intravaginal administration of 0%, 0.25%, 0.5%, and 1.0% DHEA ...
Fernand, Labrie +19 more
openaire +2 more sources
Intravaginal administration of progesterone: enhanced absorption after estrogen treatment
Fertility and Sterility, 1981A progesterone solution was administered by intravaginal instillation, intramuscular injection, and sublingually to estrogen-deficient women, with or without estradiol (E2) replacement, and serum progesterone (P) concentrations were measured by radioimmunoassay. Intravaginal application to postmenopausal subjects receiving E2 gave the highest values of
B, Villanueva, R F, Casper, S S, Yen
openaire +2 more sources
Intravaginal Administration of Conjugated Estrogens in Premenopausal and Postmenopausal Women
International Journal of Gynecology & Obstetrics, 1980ABSTRACTDaily doses of 0.625 mg of conjugated estrogens were administered intravaginally for 14 days to 12 postmenopausal women (six with highly atrophic and six with slightly atrophic vaginal mucosa), resulting in vaginal mucosae similar to those found in premenopausal women in all 12 subjects.
M, Furuhjelm, E, Karlgren, K, Carlström
openaire +2 more sources
Intravaginal oestrogen and progestin administration: advantages and disadvantages
Best Practice & Research Clinical Obstetrics & Gynaecology, 2008The vagina provides a local and a systemic route for delivering hormones for systemic effects and uterine targeting. Due to the 'uterine first-pass effect', hormones concentrate in the uterus and nearby tissues with low systemic exposure. Vaginal oestrogens, progesterone/progestins and danazol are currently used to obtain local (vagina and urethra ...
openaire +2 more sources
Mid-trimester abortion induced by intravaginal administration of prostaglandin E2 suppositories
American Journal of Obstetrics and Gynecology, 1975Mid-trimester abortion was successfully induced in 70 of 71 patients by administration of vaginal PGE2 suppositories. The one patient who failed to abort with this method was pregnant in the blind horn of a duplex uterus. The mean abortion time for the successful inductions was 11.88 hours.
N H, Lauersen, N J, Secher, K H, Wilson
openaire +2 more sources